Want to see MPLT full AI Analyst Report?
MPLT Analyst Ratings
Strong Buy
10 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MPLT Stock 12 Month Forecast
Average Price Target
$41.22
▲(135.69% Upside)
| Highest Price Target$48.00 | Average Price Target$41.22 | Lowest Price Target$34.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
LifeSci Capital
$45
Buy
157.29%
Upside
Reiterated
07/02/26
Raymond James
$46
Buy
163.01%
Upside
Initiated
06/25/26
H.C. Wainwright
$45
Buy
157.29%
Upside
Reiterated
06/23/26
Craig-Hallum
$43→$40
Buy
128.70%
Upside
Reiterated
06/23/26
Needham
$37→$42
Buy
140.14%
Upside
Assigned
06/22/26
Morgan Stanley
$34
Buy
94.40%
Upside
Reiterated
06/22/26
Stifel Nicolaus
$28→$36
Buy
105.83%
Upside
Reiterated
06/02/26
UBS
$48
Buy
174.44%
Upside
Initiated
05/27/26
Canaccord Genuity
$35
Buy
100.11%
Upside
Reiterated
05/15/26
TD Cowen
―
Buy
―
Reiterated
05/14/26
Leerink Partners
$30
Buy
71.53%
Upside
Initiated
11/21/25
Jefferies
$32
Buy
82.96%
Upside
Initiated
11/21/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
LifeSci Capital
$45
Buy
157.29%
Upside
Reiterated
07/02/26
Raymond James
$46
Buy
163.01%
Upside
Initiated
06/25/26
H.C. Wainwright
$45
Buy
157.29%
Upside
Reiterated
06/23/26
Craig-Hallum
$43→$40
Buy
128.70%
Upside
Reiterated
06/23/26
Needham
$37→$42
Buy
140.14%
Upside
Assigned
06/22/26
Morgan Stanley
$34
Buy
94.40%
Upside
Reiterated
06/22/26
Stifel Nicolaus
$28→$36
Buy
105.83%
Upside
Reiterated
06/02/26
UBS
$48
Buy
174.44%
Upside
Initiated
05/27/26
Canaccord Genuity
$35
Buy
100.11%
Upside
Reiterated
05/15/26
TD Cowen
―
Buy
―
Reiterated
05/14/26
Leerink Partners
$30
Buy
71.53%
Upside
Initiated
11/21/25
Jefferies
$32
Buy
82.96%
Upside
Initiated
11/21/25
Best Analysts Covering MapLight Therapeutics, Inc.
3 Months
Success Rate
2/2 ratings generated profit
Average Return
+44.70%
Copying Sumant Kulkarni's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +44.70% per trade.
1 Year
Success Rate
3/3 ratings generated profit
Average Return
+94.17%
Copying Paul Matteis's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +94.17% per trade.
2 Years
Success Rate
3/3 ratings generated profit
Average Return
+94.17%
Copying Paul Matteis's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +94.17% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MPLT Analyst Recommendation Trends
Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
1
2
6
7
6
Buy
0
1
8
14
14
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
3
14
21
20
Each month's total comprises the sum of three months' worth of ratings.
MPLT Financial Forecast
MPLT Stock Forecast FAQ
What is MPLT’s average 12-month price target, according to analysts?
Based on analyst ratings, MapLight Therapeutics, Inc.’s 12-month average price target is 41.22.
What is MPLT’s upside potential, based on the analysts’ average price target?
MapLight Therapeutics, Inc. has 135.69% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MPLT a Buy, Sell or Hold?
MapLight Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.
What is MapLight Therapeutics, Inc.’s price target?
The average price target for MapLight Therapeutics, Inc. is 41.22. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $48.00 ,the lowest forecast is $34.00. The average price target represents 135.69% Increase from the current price of $17.49.
The highest analyst price target is $48.00 ,the lowest forecast is $34.00. The average price target represents 135.69% Increase from the current price of $17.49.
What do analysts say about MapLight Therapeutics, Inc.?
MapLight Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of MPLT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.